09:15 AM EST, 01/15/2025 (MT Newswires) -- Health care stocks were rising premarket Wednesday, with The Health Care Select Sector SPDR Fund ( XLV ) up 0.8% and the iShares Biotechnology ETF (IBB) 1.8% higher.

Keros Therapeutics ( KROS ) shares were down 25% after the company said it has voluntarily halted all dosing in its phase 2 TROPOS trial for cibotercept in patients with pulmonary arterial hypertension due to "new observations of pericardial effusion adverse events."

NeoGenomics ( NEO ) stock was over 6% higher after the company said it expects 2025 total revenues in the range of $735 million to $745 million. Analysts surveyed by FactSet expect $727.8 million.

Context Therapeutics ( CNTX ) shares were more than 10% higher after the company said it has dosed the first patient in the phase 1 study of CTIM-76, its lead drug candidate targeting Claudin 6-positive gynecologic and testicular cancers.